AKBA Akebia Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 5, 2026
$0,87
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$0,8152tyg. minimum
$3,2052tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Przychody (TTM)
$219M
Twoje odznaki
Zakres 52 tyg.
$1–$3
Ocena Analityków
BUY
Cena Docelowa
$4
P/E
-7.9
ROE
-109.4%
Marża Zysku Netto
-13.5%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
AKBA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.86
Kapitalizacja Rynkowa (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Przychody (TTM)
$219M
ROE (TTM)
-109.4%
D/E Dług/Kapitał (MRQ)
2.0
Zakres 52 tyg.
$1–$3
AKBA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$236M2020-12-31 → 2025-12-31
EPS$-0.022020-12-31 → 2025-12-31
Wolny przepływ pieniężny$68M2020-12-31 → 2025-12-31
Marża netto-13.5%2020-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | AKBA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -7.9średnia z 5 lat ≈-22.9 | ≈-22.9 | · | · | |
| P/S (TTM) | 1.1średnia z 5 lat ≈1.9 | ≈1.9 | 26.3 | Niedowartościowany | |
| P/B (MRQ) | 9.4średnia z 5 lat ≈-1.2 | ≈-1.2 | 2.9 | Zawyżona wycena | |
| EV / EBITDA | 4.0średnia z 5 lat ≈-0.3 | ≈-0.3 | · | · | |
| Cena / FCF (TTM) | 5.8średnia z 5 lat ≈-4.8 | ≈-4.8 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 5.7średnia z 5 lat ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue (EV / Przychody) | 0.4średnia z 5 lat ≈1.7 | ≈1.7 | · | · | |
| EV / FCF | 1.4średnia z 5 lat ≈-5.3 | ≈-5.3 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | AKBA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -6.9%średnia z 5 lat ≈-18.2% | ≈-18.2% | -472.2% | Najwyższa półka | |
| EBITDA Margin (Marża EBITDA) | 10.0%średnia z 5 lat ≈-18.1% | ≈-18.1% | -469.9% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | -12.7%średnia z 5 lat ≈-26.0% | ≈-26.0% | -115.1% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | -13.5%średnia z 5 lat ≈-26.1% | ≈-26.1% | -420.3% | Najwyższa półka | |
| ROA (TTM) | -8.5%średnia z 5 lat ≈-17.2% | ≈-17.2% | -28.8% | Najwyższa półka | |
| ROE (TTM) | -109.4%średnia z 5 lat ≈90.2% | ≈90.2% | -36.9% | Najwyższa półka | |
| ROIC | 41.7% | · | 0.40% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | AKBA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 2.0średnia z 5 lat ≈-0.1 | ≈-0.1 | · | · | |
| Wskaźnik bieżący (MRQ) | 1.4średnia z 5 lat ≈1.4 | ≈1.4 | 5.9 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.4średnia z 5 lat ≈1.1 | ≈1.1 | 5.5 | Niska płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 1.0średnia z 5 lat ≈0.0 | ≈0.0 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | AKBA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 47.5%średnia z 5 lat ≈8.6% | ≈8.6% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -6.9%średnia z 5 lat ≈-9.6% | ≈-9.6% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -4.3% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | AKBA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.7 | ≈0.7 | 0.2 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 2.5średnia z 5 lat ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Rotacja należności) | 5.8średnia z 5 lat ≈5.6 | ≈5.6 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$1.2M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
49.6%
Następny raport
Lis 09, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 5, 2026 | $-0.03 | $-0.04 | 33.2% |
| 31 marca 2026 | Maj 11, 2026 | $-0.03 | $-0.03 | -4.9% |
| 31 grudnia 2025 | $-0.05 | $-0.03 | -96.1% | |
| 30 września 2025 | $0.00 | $-0.02 | 100.0% | |
| 30 czerwca 2025 | $0.00 | $-0.02 | 100.0% | |
| 31 marca 2025 | $0.03 | $-0.05 | 165.4% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $-0.22 | $-0.16 | · | $0.43 | $1.67 | $3.24 | $5.44 | $2.51 | $1.76 | $4.27 | $5.11 | |
| Revenue / Share | $0.92 | $0.76 | $1.04 | $1.60 | $1.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.26 | $-0.19 | $-0.12 | $-0.40 | $-1.52 | · | · | · | · | · | · | · | |
| Cash / Share | $0.70 | $0.23 | $0.22 | · | $0.85 | $1.54 | $1.21 | $0.90 | $1.47 | $4.85 | $1.62 | $1.61 | |
| EPS (TTM) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | $-1.86 | $-1.86 | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | · | 264,786,432 | 262,565,500 | 235,497,720 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | · | 274,372,722 | 271,104,020 | 241,602,853 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.10 | · | $0.16 | $0.11 | $0.09 | · | $-0.24 | $-0.16 | $-0.13 | · | $-0.21 | $-0.14 | $-0.08 | · | $0.08 | |
| Revenue / Share | $0.18 | $0.20 | · | $0.21 | $0.23 | $0.24 | · | $0.18 | $0.21 | $0.16 | · | $0.22 | $0.30 | $0.22 | · | $0.27 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.57 | $0.61 | · | $0.63 | $0.52 | $0.43 | · | $0.16 | $0.19 | $0.20 | · | $0.25 | $0.28 | $0.31 | · | $0.79 | |
| EPS (TTM) | $-0.11 | $-0.08 | · | $-0.07 | $-0.17 | $-0.21 | · | $-0.22 | $-0.20 | $-0.22 | · | $-0.32 | $-0.53 | $-0.32 | · | $-0.89 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $232M | · | $225M | $204M | $185M | · | $170M | $174M | $187M | · | $194M | $201M | $271M | · | $294M | |
| Net Income TTM | $-30M | $-21M | · | $-16M | $-36M | $-45M | · | $-46M | $-40M | $-43M | · | $-59M | $-98M | $-58M | · | $-158M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -10.4 | -17.4 | · | -39.0 | -21.4 | -9.1 | · | -6.0 | -5.1 | -8.3 | · | -3.6 | -1.7 | -1.8 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.2 | 4.7 | 2.7 | · | 1.6 | 1.2 | 2.0 | · | 1.1 | 0.9 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.7 | 4.3 | 2.4 | · | 1.7 | 1.2 | 2.0 | · | 1.1 | 0.8 | 0.4 | · | -0.1 | |
| Earnings Yield | -9.7% | -5.8% | · | -2.6% | -4.7% | -10.9% | · | -16.7% | -19.6% | -12.0% | · | -28.1% | -57.9% | -57.1% | · | -281.6% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Przychody | $236M | $160M | $195M | · | $292M |
| Marża Operacyjna % | 10.0% | -31.5% | -23.8% | · | -27.6% |
| Zysk netto | $-5M | $-69M | $-52M | · | $-94M |
| Rozwodniony EPS | $-0.02 | $-0.33 | $-0.28 | · | $-0.52 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 1.5 | -0.8 | -1.1 | · | · |
| Wskaźnik bieżący | 1.6 | 1.4 | 1.2 | · | · |
| Wskaźnik Szybkości | 1.4 | 1.1 | 0.8 | · | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $68M | $-41M | $-23M | · | $-73M |
Właściciele instytucjonalni (13F) 180 emitentów · $144.4M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
180
Wartość posiadanych akcji
$144.4M
Nowe pozycje
39
Zamknięte pozycje
35
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 39 (+4 vs poprzedni kw.) | 35 (+8 vs poprzedni kw.) | 68 (+25 vs poprzedni kw.) | 34 (-20 vs poprzedni kw.) | +6.7M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $25 786 481 | 16 016 448 | 17,86% | Akcje |
| BlackRock, Inc. | $22 784 466 | 19 986 374 | 15,78% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 907 243 | 11 322 143 | 8,94% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $10 432 737 | 9 151 524 | 7,23% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $7 671 148 | 6 727 302 | 5,31% | Akcje |
| STATE STREET CORP | $6 145 572 | 5 390 853 | 4,26% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4 871 250 | 4 273 026 | 3,37% | Akcje |
| GOLDMAN SACHS GROUP INC | $4 205 650 | 3 689 167 | 2,91% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $3 644 130 | 3 196 605 | 2,52% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 888 734 | 2 533 977 | 2,00% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $2 777 807 | 2 436 673 | 1,92% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 622 499 | 2 300 438 | 1,82% | Akcje |
| NORTHERN TRUST CORP | $2 462 816 | 2 160 365 | 1,71% | Akcje |
| Nantahala Capital Management, LLC | $2 280 000 | 2 000 000 | 1,58% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 176 029 | 1 908 797 | 1,51% | Akcje |
| FMR LLC | $2 133 008 | 1 871 059 | 1,48% | Akcje |
| Qube Research & Technologies Ltd | $2 028 866 | 1 779 707 | 1,41% | Akcje |
| CITADEL ADVISORS LLC | $1 958 131 | 1 717 659 | 1,36% | Akcje |
| UBS Group AG | $1 567 442 | 1 374 950 | 1,09% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 395 318 | 1 223 963 | 0,97% | Akcje |
| CITIGROUP INC | $1 282 010 | 1 124 570 | 0,89% | Akcje |
| MORGAN STANLEY | $799 756 | 701 540 | 0,55% | Akcje |
| Invesco Ltd. | $792 218 | 694 928 | 0,55% | Akcje |
| MANGROVE PARTNERS IM, LLC | $760 328 | 666 954 | 0,53% | Akcje |
| AMERIPRISE FINANCIAL INC | $713 823 | 626 160 | 0,49% | Akcje |
| Bank of New York Mellon Corp | $705 830 | 619 149 | 0,49% | Akcje |
| Nuveen, LLC | $680 123 | 596 599 | 0,47% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672 396 | 589 821 | 0,47% | Akcje |
| TWO SIGMA ADVISERS, LP | $643 918 | 399 949 | 0,45% | Akcje |
| CHOREO, LLC | $641 162 | 562 423 | 0,44% | Akcje |
| Quantinno Capital Management LP | $640 820 | 562 123 | 0,44% | Akcje |
| Creative Planning | $622 144 | 545 740 | 0,43% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606 265 | 531 813 | 0,42% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $531 832 | 466 519 | 0,37% | Akcje |
| BANK OF AMERICA CORP /DE/ | $522 976 | 458 750 | 0,36% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $493 325 | 354 910 | 0,34% | Akcje |
| Eversept Partners, LP | $486 888 | 427 095 | 0,34% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $408 376 | 358 627 | 0,28% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $368 904 | 323 600 | 0,26% | Akcje |
| VIRTUS ADVISERS, LLC | $359 940 | 315 737 | 0,25% | Akcje |
| RHUMBLINE ADVISERS | $350 544 | 307 503 | 0,24% | Akcje |
| Russell Investments Group, Ltd. | $342 416 | 300 367 | 0,24% | Akcje |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336 186 | 294 900 | 0,23% | Akcje |
| ALPS ADVISORS INC | $310 379 | 272 262 | 0,21% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304 722 | 267 300 | 0,21% | Opcja sprzedaży |
| JPMORGAN CHASE & CO | $298 634 | 269 040 | 0,21% | Akcje |
| DEUTSCHE BANK AG\ | $292 847 | 256 883 | 0,20% | Akcje |
| FRANKLIN RESOURCES INC | $286 156 | 251 014 | 0,20% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279 072 | 244 800 | 0,19% | Opcja kupna |
| WELLS FARGO & COMPANY/MN | $270 084 | 236 916 | 0,19% | Akcje |
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 zgłoszenia | 11 stycznia 2019 | · | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 zgłoszenia | 21 grudnia 2018 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 zgłoszenia | 10 sierpnia 2017 | · | Pierwotne zgłoszenie | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 zgłoszenia | 20 stycznia 2016 | · | Pierwotne zgłoszenie | · | SEC |
| Novo A/S ×3 zgłoszenia | 18 listopada 2015 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 38 insiderów · 17 dyrektorzy generalni · 20 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John P. Butler | CEO and President | 6 sierpnia 2026 M | 3 718 564 | 1 | 4 | $-387 825 |
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 29 czerwca 2026 S | 616 616 | 0 | 2 | $-110 763 |
| Ellen Snow | SVP, CFO and Treasurer | 31 stycznia 2024 A | 519 300 | 0 | 0 | $0 |
| David A Spellman | SVP, CFO and Treasurer | 16 maja 2023 S | 446 483 | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 28 lutego 2020 A | 144 642 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Operating Officer | 13 maja 2024 S | 672 092 | 0 | 0 | $0 |
| Carolyn M. Rucci | SVP, Chief Legal Officer | 2 lutego 2026 S | 588 378 | 0 | 3 | $-96 983 |
| Richard C Malabre | SVP, Chief Accounting Officer | 2 lutego 2026 S | 299 390 | 0 | 2 | $-68 838 |
| Nicholas Grund | Chief Commercial Officer | 2 lutego 2026 S | 561 750 | 0 | 2 | $-117 912 |
| Steven Keith Burke | SVP, Chief Medical Officer | 2 lutego 2026 S | 948 432 | 0 | 3 | $-94 044 |
| Nicole R. Hadas | SVP, Chief Legal Officer | 13 maja 2024 S | 651 243 | 0 | 0 | $0 |
| Violetta Cotreau | SVP, Chief Accounting Officer | 12 maja 2022 A | 219 954 | 0 | 0 | $0 |
| Dell Faulkingham | SVP, CCO | 28 lutego 2022 A | 173 841 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 28 lutego 2020 A | 84 679 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 11 kwietnia 2019 D | 96 332 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 21 lutego 2017 A | 64 585 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 14 maja 2014 A | 264 556 | 0 | 0 | $0 |
| Ron Frieson | Dyrektor | 17 czerwca 2026 A | 165 200 | 0 | 0 | $0 |
| Myles Wolf | Dyrektor | 17 czerwca 2026 A | 169 081 | 0 | 0 | $0 |
| Cynthia Smith | Dyrektor | 17 czerwca 2026 A | 196 633 | 0 | 0 | $0 |
| Adrian Adams | Dyrektor | 17 czerwca 2026 A | 236 200 | 0 | 0 | $0 |
| Michael W Rogers | Dyrektor | 17 czerwca 2026 A | 197 429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Dyrektor | 17 czerwca 2026 A | 145 100 | 0 | 0 | $0 |
| Philip J. Vickers | Dyrektor | 1 kwietnia 2026 A | · | 0 | 0 | $0 |
| Steven C Gilman | Dyrektor | 10 czerwca 2025 A | 152 830 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Dyrektor | 2 czerwca 2021 A | 48 586 | 0 | 0 | $0 |
| Mark J Enyedy | Dyrektor | 5 czerwca 2020 A | 31 143 | 0 | 0 | $0 |
| Maxine Gowen | Dyrektor | 5 czerwca 2020 A | 24 133 | 0 | 0 | $0 |
| Jodie Pope Morrison | Dyrektor | 6 czerwca 2019 A | 58 619 | 0 | 0 | $0 |
| Scott A Canute | Dyrektor | 6 czerwca 2019 A | 13 700 | 0 | 0 | $0 |
| Michael D. Clayman | Dyrektor | 14 czerwca 2018 A | · | 0 | 0 | $0 |
| Duane Nash | Dyrektor | 14 czerwca 2018 A | 21 499 | 0 | 0 | $0 |
| Ronald C Renaud JR | Dyrektor | 14 czerwca 2018 A | 5 000 | 0 | 0 | $0 |
| Satter Muneer A | Dyrektor | 14 czerwca 2018 A | 3 037 042 | 0 | 0 | $0 |
| Michael S Wyzga | Dyrektor | 14 czerwca 2018 A | 1 500 | 0 | 0 | $0 |
| Anupam Dalal | Dyrektor | 16 czerwca 2016 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | · | 25 marca 2014 C | 1 516 387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | · | 25 marca 2014 C | 3 405 764 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 17 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,52% | 130 501 SH | 1 października 2026 | Dziennie |
| IWC · iShares Trust | 0,06% | 873 651 SH | 11 września 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 249 458 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 451 303 SH | 1 października 2026 | Dziennie |
| IWO · iShares Trust | 0,01% | 2 169 896 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 123 445 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 485 665 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 6 668 524 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 364 328 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 46 198 SH | 3 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 3 164 884 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7 912 283 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24 210 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20 230 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,00% | 754 414 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 338 893 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 623 464 SH | 11 września 2026 | Dziennie |
AKBA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 11 analityków
KUP
Średni cel
$4.00
+362,4%
4 36,4%
Mocne kupno
5 45,5%
Kup
2 18,2%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
6 analityków · 2026-10-03Średnia cel $3.92 +352,8%
← Poniżej wszystkich celów
Aktualna cena $0.86
Niski$1.00
Średnia$3.92
Wysoki$6.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 5, 2026